These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6322145)

  • 41. [Preventive treatment of hemolytic disease of the newborn by use of anti-Rh(D) immunoglobulins].
    Vavrik R; Skorczyński M; Skrzypulec Z
    Akush Ginekol (Mosk); 1968 Oct; 44(10):24-6. PubMed ID: 5760959
    [No Abstract]   [Full Text] [Related]  

  • 42. Rh immunoglobulin prophylaxis.
    Riley EN
    NITA; 1983; 6(6):420-2. PubMed ID: 6316207
    [No Abstract]   [Full Text] [Related]  

  • 43. Immuno-prevention of Rh hemolytic disease of the newborn.
    McConnell RB; Woodrow JC
    Annu Rev Med; 1974; 25():165-78. PubMed ID: 4132885
    [No Abstract]   [Full Text] [Related]  

  • 44. [Expanded rhesus prophylaxis].
    Maroni ES
    Schweiz Rundsch Med Prax; 1987 Nov; 76(45):1254-9. PubMed ID: 2827286
    [No Abstract]   [Full Text] [Related]  

  • 45. [The number of neonates treated with exchange transfusion for hemolytic disease due to Rh isoimmunization before and after the administration of anti-Rho (D) immunoglobulin prophylactically].
    Hodr R
    Cesk Gynekol; 1986 Mar; 51(2):95-6. PubMed ID: 3006930
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intravenous anti-D immunoglobulins. (Prevention of anti-Rh immunization in France)].
    Jouvenceaux A
    Pathologica; 1972; 64(929):91-9. PubMed ID: 4210233
    [No Abstract]   [Full Text] [Related]  

  • 47. Controlling Rh haemolytic disease of the newborn in India.
    Joseph KS
    Br J Obstet Gynaecol; 1991 Apr; 98(4):369-77. PubMed ID: 1851635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary report on a prepregnancy counselling clinic.
    Smith NC; Byrne A; Whittle MJ
    Br J Hosp Med; 1987 Apr; 37(4):320, 322-3. PubMed ID: 3580685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.
    Thornton JG; Page C; Foote G; Arthur GR; Tovey LA; Scott JS
    BMJ; 1989 Jun; 298(6689):1671-3. PubMed ID: 2547468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is antenatal antibody screening worthwhile in Chinese?
    Wong KF; Tse KT; Lee AW; Mak CS; So CC
    Br J Haematol; 1997 Jun; 97(4):917-9. PubMed ID: 9217197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
    di Maria H; Parnet Mathieu F; Rio di Maria D; Maigret P; Gire R; Guillot F; Lasfargues G; Brossard Y
    Arch Fr Pediatr; 1990 Feb; 47(2):125-7. PubMed ID: 2158285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy--effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja)?].
    Heim MU; Weidemann R; Brehm G; Versmold H; Mempel W
    Beitr Infusionsther; 1990; 26():302-6. PubMed ID: 1703859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of Rh hemolytic disease--ten years' clinical experience with Rh immune globulin.
    Freda VJ; Gorman JG; Pollack W; Bowe E
    N Engl J Med; 1975 May; 292(19):1014-6. PubMed ID: 804134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 58. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
    Bowen FW; Renfield M
    Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rh immunoglobulin use with placenta previa and abruptio placentae.
    Grimes DA; Steele AO; Hatcher RA
    South Med J; 1983 Jun; 76(6):743-5, 749. PubMed ID: 6602383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis.
    Br J Obstet Gynaecol; 1978; 85 Suppl 2():1-41. PubMed ID: 104726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.